desipramine has been researched along with thapsigargin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cristòfol, RM; Gassó, S; Rodríguez-Farré, E; Sanfeliu, C; Suñol, C | 1 |
Chang, HT; Chen, WC; Huang, JK; Jan, CR; Jiann, BP; Lu, YC; Tseng, LL; Wang, JL | 1 |
Chen, IS; Cheng, HH; Chou, CT; Chu, ST; Hsu, SS; Huang, CJ; Jan, CR; Kuo, CC; Lin, KL; Liu, SI; Lu, YC; Tseng, LL; Wang, JL | 1 |
3 other study(ies) available for desipramine and thapsigargin
Article | Year |
---|---|
Pharmacological characterization of the effects of methylmercury and mercuric chloride on spontaneous noradrenaline release from rat hippocampal slices.
Topics: Adrenergic Uptake Inhibitors; Amiloride; Animals; Caffeine; Calcium; Calcium Channel Blockers; Chelating Agents; Chromatography, High Pressure Liquid; Cobalt; Desipramine; Egtazic Acid; Enzyme Inhibitors; Hippocampus; Male; Mercuric Chloride; Methylmercury Compounds; Norepinephrine; omega-Conotoxin GVIA; Rats; Rats, Wistar; Reserpine; Ruthenium Red; Sodium Channel Blockers; Sodium-Calcium Exchanger; Synapses; Tetrodotoxin; Thapsigargin | 2000 |
Effect of the antidepressant desipramine on cytosolic Ca(2+) movement and proliferation in human osteosarcoma cells.
Topics: Antidepressive Agents; Calcium; Calcium Signaling; Desipramine; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fura-2; Humans; Osteosarcoma; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases | 2003 |
Desipramine-induced Ca2+ movement and cytotoxicity in PC3 human prostate cancer cells.
Topics: Antidepressive Agents; Calcium; Calcium Signaling; Cell Survival; Chelating Agents; Desipramine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fura-2; Humans; Male; Prostatic Neoplasms; Thapsigargin | 2007 |